UCB SA(UCB.BR)— 技术面状态
数据截至2026-10-12 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades -4.4% vs the 50-day and -15.9% vs the 200-day average, 29.3% below the 52-week high and +2.6% off the 52-week low; a death cross printed 45 sessions ago. Computed from daily closes.
均线状态
- 相对20日均线-1.6%
- 相对50日均线-4.4%
- 相对200日均线-15.9%
- 52周区间低于52周高点29.3% · 高于52周低点2.6%
- 连续走势连续2个交易日上涨
- 均线交叉死叉(45个交易日前)
- 50日均线交叉股价向下穿越50日均线(52个交易日前)
- 随机指标%K 28.1 · %D 23.3(金叉)
相关页面: UCB.BR图表与概览 · 质量与财务体检 · 信号看板
FAQ · from the current data · as of 2026-10-12
Quick answers
UCB.BR当前的Closelook信号是什么?
Downtrend stack — Trades -4.4% vs the 50-day and -15.9% vs the 200-day average, 29.3% below the 52-week high and +2.6% off the 52-week low; a death cross printed 45 sessions ago. Computed from daily closes.(截至2026-10-12;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
UCB.BR目前是否位于50日和200日均线上方?
截至2026-10-12,UCB SA位于50日均线下方(-4.4%),200日均线下方(-15.9%);距20日均线-1.6%。
UCB.BR距52周高点有多远?
截至2026-10-12,低于52周高点29.3%,高于52周低点2.6%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- RPRX Royalty Pharma Plcindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- NTLA Intellia Therapeutics Incindustry